Eric Warren, Chief Commercial Officer: Mineralys Therapeutics MLYS Sell · Filed 06/30

Trade details

Type: Insider sale
Amount: $2,696,811.6
Shares · price: 104,124 sh · $25.90 a share
Held after: 38,400 sh
Stock: Mineralys Therapeutics MLYS
Person: Eric WarrenChief Commercial Officer
Trade date: 26/06/26
Filed: 26/06/30
Days to filing: 4 days

Sold 73.1% of holdings

Share of holding sold: 73.1%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 05/27~07/26

Eric Warren's recent trades

Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$209.1K
7,438 sh
$209.1K
Filed 09/21
Traded 09/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$193.2K
7,437 sh
$193.2K
Filed 08/21
Traded 08/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$199.9K
7,438 sh
$199.9K
Filed 07/21
Traded 07/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/29
Traded 06/26
Eric WarrenChief Commercial Officer
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$106
108 sh
$106
Filed 25/04/21
Traded 25/04/17